国际眼科纵览 ›› 2024, Vol. 48 ›› Issue (4): 316-320.doi: 10.3760/cma.j.issn.1673-5803.2024.04.013

• 综述 • 上一篇    

眼及系统性疾病的泪液生物标志物

王越1  谢小东2   

  1. 1新疆医科大学,乌鲁木齐 830054; 2新疆维吾尔自治区人民医院眼科医学诊疗中心,乌鲁木齐 830001
  • 收稿日期:2024-05-01 出版日期:2024-08-22 发布日期:2024-08-08
  • 通讯作者: 谢小东,Email:thinkpad.xj@foxmail.com
  • 基金资助:
    天山创新团队计划(2023D14008)

Tear biomarkers for ocular and systemic diseases

Wang Yue1, Xie Xiaodong2   

  1. 1 Xinjiang Medical University, Urumqi 830054, China; 2 Ophthalmic Center, the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
  • Received:2024-05-01 Online:2024-08-22 Published:2024-08-08
  • Contact: Xie Xiaodong, Email: thinkpad.xj@foxmail.com
  • Supported by:
    Tianshan Innovation Team Plan (2023D14008)

摘要: 泪液中含有大量蛋白质、细胞因子等物质参与调节眼部多种细胞的功能及代谢,进而反映个体病理生理状态。随着微量样本分析技术的提高,泪液凭借其易于获取、方便保存、性质稳定等优势已成为检测疾病潜在生物标志物的理想来源。青光眼、角膜炎、甲状腺相关性眼病,甚至某些系统性疾病(阿尔茨海默症、糖尿病、肿瘤)泪液中潜在生物标志物发生变化,对其检测或许会为这些疾病的预防及早期诊断提供一定的临床参考价值。(国际眼科纵览,2024, 48:316-320)


关键词: 泪液, 眼部疾病, 系统性疾病, 生物标志物

Abstract: Tear fluid contains a large number of proteins, cytokines and other substances involved in regulating the function and metabolism of a variety of cells in the eye, thus reflecting the individual pathophysiological state. With the improvement of micro-sample analysis technology, tear fluid has become an ideal source for the detection of potential biomarkers of diseases due to its easy accessibility, convenient storage and stable nature. Glaucoma, keratitis, thyroid-related eye diseases, and even some systemic diseases (Alzheimer's disease, diabetes mellitus, tumors) are associated with changes in potential biomarkers in tear fluid, and their detection may provide some clinical reference value for the prevention and early diagnosis of these diseases.(Int Rev Ophthalmol, 2024, 48:  316-320)


Key words: tears, ocular diseases, systemic diseases, biomarkers